Helius Medical Technologies, Inc. (HSDT) Stock Forecast
HSDT analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.50 / 5 from 2 analysts
- Price target
- $3.50 average of analyst targets
- Upside to target
- +56.2% from the latest close
- Next earnings
- November 17, 2026 EPS estimate $0.02
- 52-week range
- $1.27 – $7.00
HSDT analyst ratings
2 analystsNumber of analysts at each rating.
HSDT price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
HSDT earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.01 | −$0.04 | $0.02 | — | — | 2 |
| Current fiscal year (2026) | −$1.71 | −$1.71 | −$1.71 | — | — | 1 |
| Next fiscal year (2027) | −$0.11 | −$0.11 | −$0.11 | −$1.71 | +93.6% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
HSDT revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.9M | $2.7M | $3.0M | +308.9% | 2 |
| Current fiscal year (2026) | $12.2M | $11.5M | $13.0M | — | 2 |
| Next fiscal year (2027) | $13.8M | $10.7M | $17.0M | +13.1% | 2 |
HSDT EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
HSDT revenue: reported and forecast
HSDT EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.01 | −$0.01 | −$0.01 | −$0.01 | −$0.01 | −33.3% | 1 up · 1 down |
| Current fiscal year (2026) | −$0.72 | −$0.72 | −$0.72 | −$1.66 | −$1.71 | +137.5% | 0 up · 2 down |
| Next fiscal year (2027) | −$0.06 | −$0.06 | −$0.02 | −$0.02 | −$0.11 | +83.3% | 1 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
HSDT earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; HSDT beat in 8 of 12.
What analysts expect from HSDT
2 analysts cover Helius Medical Technologies; their consensus rating is strong buy (4.50 on a 1–5 scale, where 5 is a strong buy). The average price target is $3.50, 56.2% above the latest close of $2.24. Analysts expect earnings of −$1.71 per share for 2026. For 2027 the average estimate is −$0.11 per share on revenue of $13.8 million. Helius Medical Technologies beat the EPS estimate in 8 of the last 12 quarters.
Related: HSDT income statement, HSDT key metrics, HSDT chart. See the HSDT stock overview for the latest quote and news.
HSDT forecast FAQ
What is Helius Medical Technologies's price target?
The average analyst price target for Helius Medical Technologies is $3.50, 56.2% above the latest close of $2.24.
Is Helius Medical Technologies a buy, hold or sell?
Of 2 analysts covering Helius Medical Technologies, 1 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Helius Medical Technologies's EPS forecast?
Analysts forecast −$1.71 per share for 2026 (range −$1.71 to −$1.71); for 2027 the estimate is −$0.11.
What is Helius Medical Technologies's revenue forecast?
The average revenue estimate for 2026 is $12.2 million; for 2027 it is $13.8 million.
When does Helius Medical Technologies report earnings?
Helius Medical Technologies is expected to report results for the quarter ending September 30, 2026 on November 17, 2026; the EPS estimate is $0.02.
Does Helius Medical Technologies usually beat earnings estimates?
Helius Medical Technologies reported EPS at or above the analyst estimate in 8 of the last 12 quarters.